Boston Marathon Charity Runner for Target Cancer Foundation

Nelson Ambrogio, Senior Vice President and General Manager of Oncology at Bayer Pharmaceuticals, US., discusses his Boston Marathon run in memory of his brother who died from a rare form of cancer called cholangiocarcinoma. Ambrogio was a charity runner for the Target Cancer Foundation (TCF), which supports initiatives at the forefront of rare cancer treatment by funding innovative research, fostering collaborations, and raising awareness among scientists, clinicians, and patients. The funds raised by TCF will help give hope to patients facing rare cancers and their families. Nelson talks about his work at Bayer and the company’s investment in a paradigm shift towards precision medicine, providing true value for people with rare cancers and the oncology space as a whole.

Nelson is a highly respected and dynamic global business leader who is dedicated to delivering innovative health care solutions to enhance people’s lives.

As the Head of the Bayer US Oncology franchise, Nelson is responsible for leading the US Sales and Marketing teams, and overseeing a portfolio of six therapies across a range of indications. Oncology is one of Bayer’s global strategic pillars, playing a fundamental role in positioning Bayer as a science leader in key areas of innovation, while realizing sustainable growth. In his current role, Nelson is a member of the Bayer Pharmaceuticals Leadership Team in the US and in the Americas.

Prior to his appointment in Oncology, Nelson was Head of the Women’s Healthcare Business Unit in the US. A multi-national healthcare executive with broad experience transforming large, complex organizations, Nelson’s career spans more than 20 years with Bayer and Schering. Nelson has held a range of leadership positions around the world, including the US, Europe, Asia/Pacific and Latin America.

Nelson resides in New Jersey with his wife and four children.